![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](at2521contents.gif)
Acta Cryst. (2008). E64, m129-m130 [ doi:10.1107/S1600536807065208 ]
![[mu]](/logos/entities/mu_rmgif.gif)
-4-Bromo-2-{1-[2-(dimethylamino)ethylimino]ethyl}phenolato)bis[ethylzinc(II)]Abstract: The title complex, [Zn2(C2H5)2(C12H16BrN2O)2], is dimeric, bridged through the O atoms of the phenolate anions. The molecule lies on a crystallographic twofold rotation axis. Each Zn atom is pentacoordinated by two N atoms and two bridging O atoms of the tridentate salicylideneiminate ligands and one C atom from an ethyl group, forming a distorted square-pyramidal environment.
Online 6 December 2007
Copyright © International Union of Crystallography
IUCr Webmaster